Erynn Gordon

Mar 19, 2015

23andMe has appointed Erynn Gordon as its new medical marketing director. Gordon is the vice chair of the New Jersey Board of Medical Examiners’ genetic counseling advisory committee. At 23andMe she will lead engagement efforts with the medical community, as well as activities related to 23andMe's clinical applications.

She was previously the president of the American Board of Genetic Counseling and chaired the National Society of Genetic Counselors' ethics advisory board. Gordon will join 23andMe's commercial marketing group led by Ruby Gadelrab, VP of commercial marketing, and work with the medical affairs team led by 23andMe Chief Medical Officer Jill Hagenkord.

Erynn Gordon

Vanderbilt Team Reports on Clinical Genetic Testing Patterns Over Two Decades

BioMérieux Confirms Full-Year Growth Guidance as Q1 Sales Rise 14 Percent

Sonrai, Paige Partner to Build AI Interface for Biopharma Researchers and Clinicians

NIH Funding Cut by 40 Percent in Trump Admin's FY2026 Budget Proposal

Illumina Lays off More Than 300 Employees